JP2012500261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012500261A5 JP2012500261A5 JP2011523814A JP2011523814A JP2012500261A5 JP 2012500261 A5 JP2012500261 A5 JP 2012500261A5 JP 2011523814 A JP2011523814 A JP 2011523814A JP 2011523814 A JP2011523814 A JP 2011523814A JP 2012500261 A5 JP2012500261 A5 JP 2012500261A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- ribose
- effective amount
- life
- decrease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 13
- 239000003795 chemical substances by application Substances 0.000 claims 10
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 6
- 206010016256 fatigue Diseases 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 206010024264 Lethargy Diseases 0.000 claims 1
- 206010041349 Somnolence Diseases 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000007937 lozenge Substances 0.000 claims 1
- 230000004630 mental health Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18949808P | 2008-08-20 | 2008-08-20 | |
| US61/189,498 | 2008-08-20 | ||
| US20812209P | 2009-02-20 | 2009-02-20 | |
| US61/208,122 | 2009-02-20 | ||
| PCT/US2009/004738 WO2010021713A1 (en) | 2008-08-20 | 2009-08-20 | Use of d-ribose for fatigued subjects |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015095225A Division JP2016014009A (ja) | 2008-08-20 | 2015-05-07 | 疲労した対象のためのｄ−リボースの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012500261A JP2012500261A (ja) | 2012-01-05 |
| JP2012500261A5 true JP2012500261A5 (enExample) | 2012-10-04 |
Family
ID=41172394
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011523814A Withdrawn JP2012500261A (ja) | 2008-08-20 | 2009-08-20 | 疲労した対象のためのｄ−リボースの使用 |
| JP2015095225A Pending JP2016014009A (ja) | 2008-08-20 | 2015-05-07 | 疲労した対象のためのｄ−リボースの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015095225A Pending JP2016014009A (ja) | 2008-08-20 | 2015-05-07 | 疲労した対象のためのｄ−リボースの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20100189785A1 (enExample) |
| EP (1) | EP2323668A1 (enExample) |
| JP (2) | JP2012500261A (enExample) |
| CN (2) | CN105232564A (enExample) |
| AU (1) | AU2009283215B2 (enExample) |
| BR (1) | BRPI0917360A2 (enExample) |
| CA (1) | CA2734769A1 (enExample) |
| WO (1) | WO2010021713A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2413942A1 (en) * | 2008-04-02 | 2012-02-08 | Bioenergy Inc. | Use of ribose in first response to acute myocardial infarction |
| CN102488669A (zh) * | 2011-12-30 | 2012-06-13 | 上海希迪制药有限公司 | 一种改善d-核糖引湿性的方法 |
| AU2015343221B2 (en) * | 2014-11-03 | 2021-04-08 | Bioenergy Life Science, Inc. | Use of D-ribose to enhance adaptation to physical stress |
| WO2017120731A1 (en) * | 2016-01-11 | 2017-07-20 | Shanghai Yao Yuan Biotechnology Co., Ltd. | Methods and compositions for reducing body weight |
| JP6542687B2 (ja) | 2016-01-28 | 2019-07-10 | 日本特殊陶業株式会社 | ガスセンサユニット |
| US10434113B2 (en) | 2016-12-16 | 2019-10-08 | The Charlotte Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| WO2019200132A1 (en) * | 2018-04-12 | 2019-10-17 | Metabolic Recovery Systems, LLC | Compositions and methods for supplementing the diet |
| WO2020041750A1 (en) * | 2018-08-24 | 2020-02-27 | The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health | Methods and compositions for treating disorders associated with muscle weakness |
| KR102435548B1 (ko) * | 2022-05-31 | 2022-08-26 | (주)에이피테크놀로지 | 액상스틱형 에너지 스포츠 음료 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4228215A1 (de) * | 1992-08-25 | 1994-03-03 | Pliml Wolfgang | Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen |
| EP1745789A1 (en) * | 1998-06-19 | 2007-01-24 | Bioenergy Inc. | Compositions comprising ribose for increasing energy in vivo |
| US6159942A (en) * | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
| US6159943A (en) * | 1999-09-24 | 2000-12-12 | Bioenergy, Inc. | Use of ribose to prevent cramping and soreness in muscles |
| CA2325033C (en) * | 1999-10-27 | 2007-05-22 | Bioenergy Inc. | Use of ribose to treat fibromyalgia |
| US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
| IT1317043B1 (it) * | 2000-06-14 | 2003-05-26 | Sigma Tau Healthscience Spa | Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio. |
| US6855727B2 (en) * | 2000-12-04 | 2005-02-15 | Yaizu Suisankagaku Industry Co., Ltd. | Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect |
| US20070191287A1 (en) * | 2004-03-18 | 2007-08-16 | Michio Yamamura | D-ribose for improving depression-like symptoms |
| US20100099630A1 (en) * | 2004-04-29 | 2010-04-22 | Maccarter Dean J | Method for improving ventilatory efficiency |
| ES2393786T3 (es) * | 2004-04-29 | 2012-12-28 | Ribocor, Inc. | Método para mejorar la eficacia ventilatoria |
| US7645742B2 (en) * | 2005-06-22 | 2010-01-12 | Advocare International, L.P. | Composition for enhancing cellular energy |
| US11861305B2 (en) | 2020-12-07 | 2024-01-02 | Hitachi, Ltd. | Word processing system and word processing method |
-
2009
- 2009-08-20 CN CN201510527242.0A patent/CN105232564A/zh active Pending
- 2009-08-20 US US12/583,430 patent/US20100189785A1/en not_active Abandoned
- 2009-08-20 WO PCT/US2009/004738 patent/WO2010021713A1/en not_active Ceased
- 2009-08-20 CA CA2734769A patent/CA2734769A1/en not_active Abandoned
- 2009-08-20 AU AU2009283215A patent/AU2009283215B2/en active Active
- 2009-08-20 EP EP09789171A patent/EP2323668A1/en not_active Withdrawn
- 2009-08-20 JP JP2011523814A patent/JP2012500261A/ja not_active Withdrawn
- 2009-08-20 CN CN2009801324503A patent/CN102215846A/zh active Pending
- 2009-08-20 BR BRPI0917360A patent/BRPI0917360A2/pt not_active Application Discontinuation
-
2012
- 2012-04-11 US US13/444,279 patent/US20120264701A1/en not_active Abandoned
-
2015
- 2015-05-07 JP JP2015095225A patent/JP2016014009A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012500261A5 (enExample) | ||
| JP2011522896A5 (enExample) | ||
| NZ611628A (en) | Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients | |
| JP2009084294A5 (enExample) | ||
| NO20085374L (no) | Anvendelse av fytat som middel for a inhibere opplosning av krystaller av kalsiumsalter for forhindring av osteoporose | |
| JP2012529334A5 (enExample) | ||
| JP2016530291A5 (enExample) | ||
| JP2011510922A5 (enExample) | ||
| MY139913A (en) | Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance | |
| JP2017190298A (ja) | 体内で水素を産生する組成物、及びサプリメント | |
| WO2011019735A3 (en) | Nutritional supplements | |
| JP2016050198A (ja) | 睡眠障害改善剤 | |
| JP2005524629A5 (enExample) | ||
| JP2008266291A5 (enExample) | ||
| HRP20060416A2 (en) | Herbal mixture and an active substance originating thereof, for enhancing immunity and improving medical treatment | |
| JP2013032308A5 (enExample) | ||
| JP6947495B2 (ja) | Ｇａｂａを有効成分とする活気および／または活力向上剤 | |
| Huijer | Chronic pain: a review | |
| JP2017527591A (ja) | 認知機能向上のための植物抽出物 | |
| EP1733631A4 (en) | FOOD COMPOSITION WITH ANTISTRESS EFFECT | |
| RU2014146562A (ru) | Композиция, содержащая альфа-липоевую кислоту и гонокиол, для лечения нейропатий | |
| Persson et al. | Age your garlic for longevity! | |
| WO2009057033A3 (en) | Computing a user's condition | |
| JP2007326799A5 (enExample) | ||
| TR200704897A1 (tr) | Uzatılmış salım sağlayan gliklazid formülasyonları@ |